Tizanidine hydrochloride
NDC 71209-065, Tizanidine hydrochloride, capsule, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-065
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210021
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-065-07 | 71209006507 | 150 CAPSULE in 1 BOTTLE (71209-065-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f2f4e117-0318-4bbd-aaa7-fab803714f21
Use it
Look up 71209-065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.